Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYJournal of community genetics

Effect of implementation of a clinical checklist on the evaluation of constitutional mismatch repair deficiency in a neurofibromatosis clinic.

9 affiliations
  1. 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
  2. 2Indiana University Health Physicians, Indianapolis, IN, USA.
  3. 3Division of Pediatric Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
  4. 4Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Indiana University School of Medicine, Indianapolis, IN, USA.
  5. 5Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA.
  6. 6Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
  7. 7Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. [email protected].
  8. 8Indiana University Health Physicians, Indianapolis, IN, USA. [email protected].
  9. 9IU Health Simon Cancer Center, 1030 W. Michigan St, Ste 3307, Indianapolis, IN, 46202, USA. [email protected].

Abstract

Background

Children with constitutional mismatch repair deficiency (CMMRD) require early and intensive cancer surveillance. Due to phenotypic overlap between CMMRD and neurofibromatosis type 1 (NF1), some children with CMMRD receive an incorrect diagnosis of NF1 and are inappropriately managed for their cancer risk. This study evaluated the effectiveness of a clinical checklist in identifying individuals for whom CMMRD evaluation is recommended.Procedure

Providers in a neurofibromatosis clinic implemented published CMMRD evaluation checklists into their clinical notes. Phase 1 of the study consisted of retrospective chart review prior to incorporation of the checklist. Phase 2 consisted of prospective chart review after checklist implementation.Results

Phase 1 included 81 patients; Phase 2 included 60 patients. In Phase 2, ambiguous ("Unknown") checklist responses were reduced, and patients were more likely to meet criteria for CMMRD evaluation. Individuals in Phase 2 were more likely to be referred for genetic evaluation compared to Phase 1. There was no correlation between patients meeting criteria for CMMRD evaluation and being referred to genetics in either cohort.Conclusions

These results suggest a clinical CMMRD checklist is a useful tool for identifying individuals for whom CMMRD evaluation is recommended. Patients with a nondiagnostic NF1 workup who meet CMMRD evaluation criteria require further follow-up to aid in appropriate diagnosis and management.

Related

  1. Implementation of the Trigger Checklist and assertive outreach to reduce drug-related harm in the Emergency Department: A realist evaluation
    Michelle Beattie, Lesley Campbell, Bev Fraser +1
    PLOS OnePeer-reviewedCC BY 4.0Full textNeuroscienceOrganic chemistryPLOS
  2. Tailoring neurofibromatosis type 1 care to Singapore: From consensus to implementation
    Eric Legius
    Annals, Academy of Medicine, SingaporePeer-reviewedCC BY-NC-SAFull textNeurologyDOAJ
  3. Implementation of a Structured Perioperative Checklist-Based Standardization Process and Early Postoperative Outcomes After Bariatric Surgery: A Single-Center Retrospective Pre–Post Cohort Study
    Sertaç Ata Güler, Mehmet Fatih Özsaray, Turgay Şimşek +1
    Journal of clinical medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
  4. What are the implementation lessons from a high-volume cataract screening and surgical programme? A mixed-methods implementation evaluation in Sierra Leone
    Gabriel Osei-Anokye, Muhammad Rabiu, Lloyd Harrison-Williams +2
    BMJ OpenPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  5. Design, implementation, and evaluation of a comprehensive educational program for microbiology laboratory personnel and graduate students in teaching hospitals
    Zohre Baseri, Gholamreza Irajian, Amin Dehghan
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
BibTeX
@article{mcdonald2026effect,
  title = {{Effect of implementation of a clinical checklist on the evaluation of constitutional mismatch repair deficiency in a neurofibromatosis clinic.}},
  author = {Bridget McDonald and Jennifer Ivanovich and Leah Wetherill and Laurence Walsh and Jayne Vonbergen and Lisa Langsford and Steven D Rhodes and Leigh Anne Stout},
  journal = {Journal of community genetics},
  year = {2026},
  month = oct,
  doi = {10.1007/s12687-026-00967-8},
  url = {https://europepmc.org/article/MED/42957923},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Effect of implementation of a clinical checklist on the evaluation of constitutional mismatch repair deficiency in a neurofibromatosis clinic.
AU  - Bridget McDonald
AU  - Jennifer Ivanovich
AU  - Leah Wetherill
AU  - Laurence Walsh
AU  - Jayne Vonbergen
AU  - Lisa Langsford
AU  - Steven D Rhodes
AU  - Leigh Anne Stout
PY  - 2026
DA  - 2026/10/30
JO  - Journal of community genetics
DO  - 10.1007/s12687-026-00967-8
UR  - https://europepmc.org/article/MED/42957923
AB  - Background  Children with constitutional mismatch repair deficiency (CMMRD) require early and intensive cancer surveillance. Due to phenotypic overlap between CMMRD and neurofibromatosis type 1 (NF1), some children with CMMRD receive an incorrect diagnosis of NF1 and are inappropriately managed for their cancer risk. This study evaluated the effectiveness of a clinical checklist in identifying individuals for whom CMMRD evaluation is recommended.Procedure  Providers in a neurofibromatosis clinic implemented published CMMRD evaluation checklists into their clinical notes. Phase 1 of the study consisted of retrospective chart review prior to incorporation of the checklist. Phase 2 consisted of prospective chart review after checklist implementation.Results  Phase 1 included 81 patients; Phase 2 included 60 patients. In Phase 2, ambiguous ("Unknown") checklist responses were reduced, and patients were more likely to meet criteria for CMMRD evaluation. Individuals in Phase 2 were more likely to be referred for genetic evaluation compared to Phase 1. There was no correlation between patients meeting criteria for CMMRD evaluation and being referred to genetics in either cohort.Conclusions  These results suggest a clinical CMMRD checklist is a useful tool for identifying individuals for whom CMMRD evaluation is recommended. Patients with a nondiagnostic NF1 workup who meet CMMRD evaluation criteria require further follow-up to aid in appropriate diagnosis and management.
SN  - 1868-310X
SN  - 1868-6001
ER  -